Skip to content

Cardio and Renovascular Effects of Isometric Exercise in the Healthy Human Measured by PET/CT and MRI

Cardio and Renovascular Effects of Static Muscle Work in the Healthy Human - Measured With Finapres® and Positron Emission Tomography (PET) Using 15-oxygen Labeled Water as Tracer Compared to Magnetic Resonance (MR)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06555211
Enrollment
10
Registered
2024-08-15
Start date
2024-05-07
Completion date
2024-12-31
Last updated
2024-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidneys

Keywords

Total renal blood flow, Regional renal perfusion, Regional renal oxygenation, Renal oxygen extraction

Brief summary

This randomized crossover study aims to validate measurements of renal perfusion in healthy males with PET/CT, using 15-oxygen labeled water as tracer, against the validated multiparametric MRI technique. The study will determine: * Total renal blood flow and regional renal perfusion at baseline (rest) and during isometric muscle exercise of the upper arm, using PET/CT (with 15-oxygen labeled water as a tracer) and MRI. * The coefficient of variation of renal blood flow and regional renal perfusion measurements at baseline and during isometric muscle exercise of the upper arm, using PET/CT (with 15-oxygen labeled water as a tracer) and MRI. * Regional renal oxygenation and oxygen extraction at baseline and during isometric muscle exercise of the upper arm using MRI. * The coefficient of variation on regional renal oxygenation and oxygen extraction measurements at baseline and during isometric muscle exercise of the upper arm using MRI.

Detailed description

Measuring tissue perfusion with PET/CT using 15-oxygen labeled water is routinely used as a non-invasive tool to examine cerebral and myocardial perfusion. With a 100% tissue extraction, 15-oxygen labeled water is gold standard. The aim of the present study is to validate renal perfusion measurements with PET/CT using 15-oxygen labeled water as tracer against the validated multiparametric MRI technique. Once validated the imaging technique will be beneficial in examining vascular damage in the kidneys caused by different renal diseases. This is a randomized, crossover study where each participant will participate in 1 study day. Ten healthy male participants in the age group 20-60 years are screened and randomized, and expected to complete the present study. Informed consent is obtained before the screening meeting. All participants consume a controlled diet with fixed salt intake corresponding to a daily intake of 50-70 mmol + 2 mmol/kg sodium for 4 days before the experiment. On the fourth day, 24-hour urine collection will be performed. Throughout the 4 day period, water intake will be ad libitum and physical activity will not be allowed. Each participant will undergo both PET/CT and MRI separated by around 1.5 hour. Total renal blood flow and regional renal perfusion are measured repeatedly altogether 5 times with both PET/CT and MRI. Renal oxygenation and oxygen extraction are measured repeatedly 5 times as well, using MRI. The 5 measurements consist of 2 at baseline (rest), 2 during isometric exercise (handgrip) and 1 during recovery (rest). Isometric muscle exercise is conducted by squeezing a handgrip coupled to a dynamometer. This increases sympathetic nervous activity, leading to preglomerular vasoconstriction.

Interventions

PROCEDUREMRI

MRI will be performed

PROCEDUREPET/CT

PET/CT will be performed

Sponsors

Bispebjerg Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Each participant will undergo intervention, which is PET/CT, and control, which is MRI. Each participant will have both intervention and control performed the same day in randomized order.

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Normal health stated through medical questionnaire, examination and blood samples.

Exclusion criteria

* Immunosuppressive treatment * Alcohol abuse * Treatment with glucocorticoids, Glucagon-like peptide-1 (GLP-1) agonists, dipeptidyl peptidase 4 (DPP-4)-inhibitors * Medical treatment affecting insulin secretion or cardiovascular endpoints * Liver disease * Decreased kidney function * Severe claustrophobia * Elements incompatible with MR.

Design outcomes

Primary

MeasureTime frameDescription
Coefficient of variation on total blood flow and regional renal perfusion measurements at rest and during isometric muscle exercise, measured by PET/CT with 15-Oxygen labeled water and MRIEach participant's study day during the span of the study (approximately 5 months)No metric unit
Total blood flow at rest and during isometric muscle exercise measured by PET/CT with 15-Oxygen labeled water and MRIEach participant's study day during the span of the study (approximately 5 months)Volume of blood pr unit time, ml/min
Regional renal perfusion at rest and during isometric muscle exercise measured by PET/CT with 15-Oxygen labeled water and MRIEach participant's study day during the span of the study (approximately 5 months)Volume of blood pr unit time pr unit tissue mass, ml/min/g
Regional renal oxygenation at rest and during isometric muscle exercise using MRIEach participant's study day during the span of the study (approximately 5 months)Percentage, fraction
Regional renal extraction of oxygen at rest and during isometric muscle exercise using MRIEach participant's study day during the span of the study (approximately 5 months)Percentage, fraction
Coefficient of variation on regional renal oxygenation and extraction of oxygen measurements at rest and isometric muscle exercise using MRIEach participant's study day during the span of the study (approximately 5 months)No metric unit

Countries

Denmark

Contacts

Primary ContactPeter Sørensen, MD
peter.soerensen@regionh.dk+4530516279
Backup ContactAli Asmar, MD, PhD
ali.asmar@regionh.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026